hVIVO specialises in delivering high-quality clinical trial services tailored to respiratory diseases, such as asthma, and COPD. Our investigators, clinical support team, and state of the art unit provide for scalable solutions, whether a study demands smaller very specific participant cohorts or larger patient cohorts. hVIVO is there to meet your site and recruitment needs.
With our team specialising in respiratory conditions, hVIVO is well positioned to support your enrolment of healthy participants as well as for a range of respiratory and related conditions, such as:
The breadth of scientific, clinical and research experience ensures that we can support diverse study requirements and deliver reliable, actionable insights for our sponsors.
Serial Spirometry
Forced Oscillation Technique (FOT)
Fractional exhaled Nitric Oxide (FeNO)
Induced sputum
Bronchodilator Responsiveness
Methacholine
Lipopolysaccharide (LPS)
Nasal Allergen Challenge (NAC)
Broncho Allergen Challenge (BAC)
Human Rhinovirus Challenge
Our clinical trial unit is supported by hVIVO’s extensive recruitment and enrolment team who engage with our healthy volunteers and patients within our active database of over 365,000. A significant number of those patients have varying atopic and respiratory conditions and include:
asthma patients
of which registered interest to be on our clinical trials within the past 24 months
of which have been categorised by GINA type, many of which have attended our asthma clinics
patients with atopic conditions
With a continuous programme of bringing patients in to be characterised, hVIVO is investing in this cohort, categorising participants for clinical trials, limiting screen failure rates and having a ready and engaged pool of participants available for studies. The database can be accessed in a variety of ways to help delivery fast enrolment into studies.
With state-of-the-art in-patient and outpatient facilities in London, hVIVO is able to cater from Phase I to Phase IV studies.
Our state-of-the-art in-patient facility at Canary Wharf:
Our dedicated outpatient unit in Whitechapel, London has:
Our Principal Investigators, clinical team, and clinical trial operations team have a diverse range of both clinical and research experiences, from respiratory, immunology, dermatology, infectious diseases, ENT, neurological, anaesthesia, and acute care. The team are supported by our clinical scientists who have significant expertise in leading the design, execution and analysis of clinical studies with special interest in infection, atopy and respiratory diseases such as asthma, COPD, IPF, and bronchiectasis.
hVIVO’s experienced screening and clinical trials team can support a range of respiratory and atopic disease trials, including assessing lung function (spirometry and FOT), FENO, methacholine challenge (AHR), nasal and bronchial allergy challenge, bronchodilator responsiveness, allergy skin prick test, induced sputum, respiratory, urinary, and haematological sampling etc. ensuring quality, actionable results with onsite CL2 and CL3 labs to facilitate specialist immunology and virology testing.
With over 20 years in infectious and respiratory challenges our experience sets us apart from other clinical trial unit CROs, ensuring close collaboration between the clinical site, onsite laboratory, clinical scientists and trial support teams. Having both clinical and scientific disciplines under one roof helps us more effectively assist our clients transition smoothly through a trial, from collaboratively developing a fit-for-purpose protocol design through to clinical study report. We partner with both pharmaceutical and biotech companies to accelerate the development of their innovative treatments for various respiratory conditions.
